Discontinued — last reported Q4 '23
Geographic · Property, plant and equipment
Emerging Markets — Property, plant and equipment
Pfizer Emerging Markets — Property, plant and equipment increased by 24.3% to $1.76B in Q4 2023 compared to the prior quarter.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2016
Last reportedQ4 2023Feb 22, 2024
Rolls up toPP&E (Net)
How to read this metric
Higher values indicate a larger physical infrastructure footprint, which may signal long-term commitment to regional market growth or increased manufacturing capacity.
Detailed definition
This metric represents the gross carrying amount of tangible long-term assets, such as land, buildings, and machinery, s...
Peer comparison
Similar to other global pharmaceutical firms, this metric provides insight into the geographic distribution of capital expenditures and infrastructure investment.
Metric ID:
pfe_segment_emerging_markets_property_plant_and_equipmentHistorical Data
3 periods
| Q4 '21 | Q4 '22 | Q4 '23 | |
|---|---|---|---|
| Value | $1.06B | $1.41B | $1.76B |
| QoQ Change | — | +33.8% | +24.3% |
| YoY Change | — | +33.8% | +24.3% |
Range$1.06B – $1.76B
Avg YoY Growth+29.0%
Median YoY Growth+29.0%
Current Streak2+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Pfizer's emerging markets — property, plant and equipment?
- Pfizer (PFE) reported emerging markets — property, plant and equipment of $1.76B in Q4 2023.
- What does emerging markets — property, plant and equipment mean?
- The total historical cost of physical assets owned by the company in emerging markets.